In recent years several NGO’s, like IFBV, promote artemisia annua tea in tropical countries. This plant has excellent therapeutical properties against malaria, as demonstrated by several clinical trials. And as it is now growing in many African gardens and schools a lot of people have noticed that if they drink this tea regularly they are immune against malaria.

These prophylactic properties have been confirmed at large scale in Kenyan schools, partners of the IDAY network. In 2010 artemisia annua plantations were extended...

In recent years several NGO’s, like IFBV, promote artemisia annua tea in tropical countries. This plant has excellent therapeutical properties against malaria, as demonstrated by several clinical trials. And as it is now growing in many African gardens and schools a lot of people have noticed that if they drink this tea regularly they are immune against malaria.

These prophylactic properties have been confirmed at large scale in Kenyan schools, partners of the IDAY network. In 2010 artemisia annua plantations were extended...

Depuis quelques années plusieurs associations, dont IFBV-Luxembourg, propagent des plantations d’artemisia annua dans les pays tropicaux. Cette plante a d’excellentes propriétés thérapeutiques contre le paludisme, comme des essais cliniques récents l’ont confirmé. Notamment ceux réalisés à grande échelle au Cameroun en 2009 (Emilien Fouda à Yaoundé et Rosine Chougouo à Bangangté) et qui avaient montré les...

Is PCR genotyping of Plasmodium falciparum a reliable tool to monitor drug resistance?

A recent press release from Wellcome Trust Sanger Institute raised a lot of concern. Based on a scientific paper published in Nature, 13 June 2012, it appears that a single infected person could harbour many genetically different Plasmodium falciparum parasites. The team from Oxford University found that these parasite populations easily swap DNA to create new forms. This evidently raises the question how far PCR (polymer chain reaction...

Hepatotoxic, cytotoxic, neurotoxic, genotoxic, embryotoxic, hemolytic, immunodepressive effects of chemical artemisinine derivatives (ACTs) at high doses.

Some recent research, mostly in relation with the resistance to ACT pills and/or artesunate injections, has highlighted serious secundary health effects at the doses prescribed by WHO.
Fears of emerging artemisin resistance in western Cambodia have promoted a series of clinical trials investigating if resistance can be overcome by increasing doses of drug. After 3 to 5...